Jincheng Wang

Dr. Jincheng Wang

Hokkaido University, Sapporo, Hokkaidō, Japan

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2023 in Pharmacology & Therapeutics
Verified
Journal Article
Closed access
HCHao Chen
Hao Chen
HTHuabing Tan
Huabing Tan
JWJuan Wan
Juan Wan
YZYong Zeng
Yong Zeng
Jincheng WangJincheng Wang
Jincheng Wang
XLXiaojie Lu
Xiaojie Lu

7 February 2018 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
XWXiaochen Wang
Xiaochen Wang
HSHaiyuan Shen
Haiyuan Shen
GZGuangyan Zhangyuan
Guangyan Zhangyuan
RHRuyi Huang
Ruyi Huang
WZWenjie Zhang
Wenjie Zhang
XLXiaojie Lu
Xiaojie Lu
Increasing evidence shows that the anti-tumor functions of tumor-infiltrating T lymphocytes (TILs) were inhibited significantly, but the underlying mechanisms remain not fully understood. In this study, we found that 14-3-3ζ expression was up-regulated in hepatocellular carcinoma (HCC) cells and in TILs. TILs with 14-3-3ζ high-expression (14-3-3ζhigh) exhibited impaired activation (CD69), proliferation (Ki67) and anti-tumor functions compared to 14-3-3ζ low expression (14-3-3ζlow) TILs. Flow cytometry assay showed that compared with 14-3-3ζlow CD8+T cells, 14-3-3ζhigh ones exhibited higher frequency of exhausted phenotypes as measured by inhibitory receptors such as PD-1, TIM-3, LAG3, and CTLA-4. 14-3-3ζ overexpression inhibited the activity and proliferation of peripheral blood CD3+ T cells, deviated the differentiation of naive T cells from effector T cells to regulatory T cells. Moreover, we found that 14-3-3ζ expression levels in TILs correlated positively with those in HCC cells. Naive T cells co-cultured with HCC cells or the visible components of culture medium of HCC cells exhibited increased 14-3-3ζ expression. Stochastic optical reconstruction microscopy (STORM) and confocal assay showed that 14-3-3ζ-containing exosomes derived from HCC cells could be swallowed by T cells, suggesting that 14-3-3ζ might be transmitted from HCC cells to TILs at least partially through exosomes. In conclusion, our study for the first time demonstrated that 14-3-3ζ is up-regulated in and inhibited the anti-tumor functions of tumor-infiltrating T cells in HCC microenvironment and that 14-3-3ζ might be transmitted from HCC cells to T cells at least partially through exosomes.

1 June 2021 in Immunity
Verified
Journal Article
Closed access
WZWenjie Zhang
Wenjie Zhang
GZGuangyan Zhangyuan
Guangyan Zhangyuan
FWFei Wang
Fei Wang
KJKangpeng Jin
Kangpeng Jin
HSHaiyuan Shen
Haiyuan Shen
BSBeicheng Sun
Beicheng Sun

1 May 2020 in Journal of Hepatology
Verified
Journal Article
Closed access
ZZZechuan Zhang
Zechuan Zhang
XXXiaoliang Xu
Xiaoliang Xu
WTWenfang Tian
Wenfang Tian
RJRunqiu Jiang
Runqiu Jiang
YLYijun Lu
Yijun Lu
BSBeicheng Sun
Beicheng Sun

1 December 2019 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
YLYi-He Liu
Yi-He Liu
XZXin-Yuan Zang
Xin-Yuan Zang
Jincheng WangJincheng Wang
Jincheng Wang
SHShan-Shan Huang
Shan-Shan Huang
JXJiang Xu
Jiang Xu
PZPeng Zhang
Peng Zhang
Immune checkpoint inhibitors (ICPIs) and chimeric antigen receptor (CAR) T-cell therapy are two main promising methods of immunotherapy, which have become increasingly important in cancer treatment. After the wider application of these medicine in clinic, a range of immune related adverse events (irAEs) covering almost any system arouse the concern for being randomness and unpredictability. Even if most adverse events are mild and controllable after thoughtful management, the occurrence of life-threatening toxicities should not be ignored because of the insidious and atypical symptoms, which makes the early diagnosis even more challenging. In this review, a brief introduction of immunotherapy and mechanisms underlying irAEs is involved. We mainly focus on the early diagnostic method and recommended management of toxicities of different systems separately, and consequently maximized effectiveness of immunotherapy can be achieved.

7 March 2018 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
Jincheng WangJincheng Wang
Jincheng Wang
YXYong Xu
Yong Xu
ZHZheng‐Ming Huang
Zheng‐Ming Huang
XLXiaojie Lu
Xiaojie Lu